Topic · page 89 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 3,521–3,560 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

J Clin Endocrinol Metab15 Nov 2023
Glycemia and Gluconeogenesis With Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes
Randomized controlled trial
J Clin Endocrinol Metab15 Nov 2023
Signs of Glucagon Resistance After a 2-Week Hypercaloric Diet Intervention
Research article
Diabet Med15 Nov 2023
The Fusion Clinic: Integrating the care of people with severe mental illness and diabetes
Research article
Diabetes Res Clin Pract14 Nov 2023
Circulating tumor necrosis factor-related biomarkers predict kidney function decline in Japanese patients with diabetes: An observational cohort study
Cohort study
Pediatr Diabetes14 Nov 2023
Incidence Trends of Type 2 Diabetes Mellitus, Medication-Induced Diabetes, and Monogenic Diabetes in Canadian Children, Then (2006–2008) and Now (2017–2019)
Cohort study
Diabetes Res Clin Pract14 Nov 2023
Once-weekly semaglutide use in glucagon-like peptide-1 receptor agonist naïve patients with type 2 diabetes in North Macedonia: Real-world data from the MIRAGE study
Cohort study
Diabetes Res Clin Pract14 Nov 2023
Effects of percutaneous coronary intervention and diabetes mellitus on short- and long-term prognosis assessed by the three-vessel quantitative flow ratio
Cohort study
BMJ Open Diabetes Res Care14 Nov 2023
Patient-reported outcome measures in diabetes outpatient care: a scoping review
Research article
Diabetes Obes Metab14 Nov 2023
Non‐alcoholic fatty liver disease is associated with brain function disruption in type 2 diabetes patients without cognitive impairment
Cross-sectional study
Diabetes Care13 Nov 2023
Chronic Insufficient Sleep in Women Impairs Insulin Sensitivity Independent of Adiposity Changes: Results of a Randomized Trial
Randomized controlled trial
Diabetes Obes Metab12 Nov 2023
A model‐informed approach to accelerate the clinical development of cofrogliptin ( HSK7653 ), a novel ultralong‐acting dipeptidyl peptidase‐4 inhibitor
Meta-analysis
Diabetes Res Clin Pract11 Nov 2023
The prevalence of diabetes distress in Chinese patients with type 2 diabetes: A systematic review and meta-analysis
Meta-analysis
Diabetes Res Clin Pract11 Nov 2023
Sex hormone-binding globulin and heart failure hospitalizations in patients with dysglycemia: Experiences from the outcome reduction with an Initial Glargine Intervention trial
Secondary analysis
Diabetes Care10 Nov 2023
Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal
Mechanistic study
BMJ Open Diabetes Res Care10 Nov 2023
Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study
Cohort study
Diabetes Res Clin Pract10 Nov 2023
Cumulative HbA1c exposure as a CVD risk in patients with type 2 diabetes: A post hoc analysis of ACCORD trial
Secondary analysis
Diabet Med10 Nov 2023
Glucagon like peptide‐1 receptor agonists and the risk of skin cancer among patients with type 2 diabetes: Population‐based cohort study
Cohort study
J Clin Endocrinol Metab10 Nov 2023
Impact of Free Fatty Acids on Vascular Insulin Responses Across the Arterial Tree: A Randomized Crossover Study
Randomized controlled trial
Nat Med9 Nov 2023
Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
Meta-analysis
Diabetes Care9 Nov 2023
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Randomized controlled trial
Diabetes Obes Metab8 Nov 2023
Weight change in patients with new‐onset type 2 diabetes mellitus and its association with remission: Comprehensive real‐world data
Cohort study
Cardiovasc Diabetol8 Nov 2023
Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
Cross-sectional study
Cardiovasc Diabetol8 Nov 2023
Triglycerides/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10
Cohort study
Cardiovasc Diabetol8 Nov 2023
Roles of gut microbiota in atrial fibrillation: insights from Mendelian randomization analysis and genetic data from over 430,000 cohort study participants
Diagnostic or prognostic study
J Diabetes Sci Technol8 Nov 2023
The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus
Guideline or statement
Diabetes Obes Metab8 Nov 2023
Effects of CB1R inverse agonist, INV ‐202, in patients with features of metabolic syndrome. A randomized, placebo‐controlled, double‐blind phase 1b study
Randomized controlled trial
Diabetologia7 Nov 2023
Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes
Cohort study
Diabetes Obes Metab7 Nov 2023
Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studies
Secondary analysis
Diabetes Obes Metab7 Nov 2023
Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: An age‐period‐cohort analysis
Cohort study
JAMA7 Nov 2023
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial
Randomized controlled trial
Diabetes Obes Metab5 Nov 2023
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post‐hoc analysis of the ROTATE ‐3 study
Secondary analysis
Diabetes Res Clin Pract4 Nov 2023
Trends in health behaviors of US adults with and without Diabetes: 2007–2018
Cross-sectional study
Diabetes Res Clin Pract3 Nov 2023
Effects of body weight variability on risks of macro- and microvascular outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort
Cohort study
Diabetologia3 Nov 2023
Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial
Randomized controlled trial
Diabetes Res Clin Pract3 Nov 2023
Glycemic outcomes of a family-focused intervention for adults with type 2 diabetes: Main, mediated, and subgroup effects from the FAMS 2.0 RCT
Randomized controlled trial
Diabetes Obes Metab3 Nov 2023
Sex‐specific causality of MRI ‐derived body compositions on glycaemic traits: Mendelian randomization and observational study
Cohort study
Diabetes Care2 Nov 2023
Risk Factors for and Risk of Peripheral Artery Disease in Swedish Individuals With Type 2 Diabetes: A Nationwide Register-Based Study
Cohort study
Diabetes Res Clin Pract2 Nov 2023
Longitudinal trajectories of glycemic control among U.S. Adults with newly diagnosed diabetes
Cohort study
Cardiovasc Diabetol2 Nov 2023
Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells
Cross-sectional study
Cardiovasc Diabetol2 Nov 2023
Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy
Cross-sectional study

All 4,758 Briefs in ExploreShowing Briefs 3,521–3,560 of 4,758, newest first